Clinical trials
Active, not recruiting Phase 1 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 3 |
| 2024 | 11 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| M.D. Anderson Cancer Center | 4 |
| Eli Lilly and Company | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Monopar Therapeutics | 2 |
| USWM CT, LLC | 2 |
| University Health Network, Toronto | 2 |
| Agenus Inc. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Anthony Joshua, FRACP | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 60 |
| Stomach Neoplasms | 18 |
| Breast Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Endometrial Neoplasms | 16 |
| Triple Negative Breast Neoplasms | 16 |
| Fallopian Tube Neoplasms | 15 |
| Colorectal Neoplasms | 14 |
| Esophageal Neoplasms | 14 |
| Lung Neoplasms | 13 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.